2009•American Heart JournalRequires access

Contribution of angiographic and electrocardiographic parameters of reperfusion to prediction of mortality and morbidity after acute ST-elevation myocardial infarction: Insights from the Assessment of Pexelizumab in Acute Myocardial Infarction trial

Sorin J. Brener, Cynthia M. Westerhout, Yuling Fu, Thomas G. Todaro, David J. Moliterno, Galen S. Wagner, Christopher B. Granger, Paul W. Armstrong

Open publisher page 10 citations

Abstract

This record does not include an abstract. Use the full-text link above if available.

About this research paper

What this paper is about

An abstract is not available in the OpenAlex record for this paper.

Why it matters

OpenAlex reports 10 citations for this work. Citation counts describe recorded attention and do not establish research quality.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Key concepts: TIMI, Medicine, Cardiology, Conventional PCI, Internal medicine, Myocardial infarction, Percutaneous coronary intervention, Thrombolysis

Back to paper search Browse research topics Original source

Contribution of angiographic and electrocardiographic parameters of reperfusion to prediction of mortality and morbidity after acute ST-elevation myocardial infarction: Insights from the Assessment of Pexelizumab in Acute Myocardial Infarction trial — Research Paper | ScholarLens